- Home
- PERI vs MRVI Comparison
PERI vs MRVI Comparison
Compare PERI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PERI
- MRVI
- Stock Information
- Founded
- PERI 1999
- MRVI 2014
- Country
- PERI Israel
- MRVI United States
- Employees
- PERI N/A
- MRVI N/A
- Industry
- PERI EDP Services
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- PERI Technology
- MRVI Health Care
- Exchange
- PERI Nasdaq
- MRVI Nasdaq
- Market Cap
- PERI 412.5M
- MRVI 376.2M
- IPO Year
- PERI 2006
- MRVI 2020
- Fundamental
- Price
- PERI $9.62
- MRVI $3.37
- Analyst Decision
- PERI Buy
- MRVI Hold
- Analyst Count
- PERI 4
- MRVI 9
- Target Price
- PERI $11.83
- MRVI $4.54
- AVG Volume (30 Days)
- PERI 220.6K
- MRVI 1.7M
- Earning Date
- PERI 11-05-2025
- MRVI 11-06-2025
- Dividend Yield
- PERI N/A
- MRVI N/A
- EPS Growth
- PERI N/A
- MRVI N/A
- EPS
- PERI N/A
- MRVI N/A
- Revenue
- PERI $424,098,000.00
- MRVI $219,830,000.00
- Revenue This Year
- PERI N/A
- MRVI N/A
- Revenue Next Year
- PERI $11.40
- MRVI $7.27
- P/E Ratio
- PERI N/A
- MRVI N/A
- Revenue Growth
- PERI N/A
- MRVI N/A
- 52 Week Low
- PERI $7.00
- MRVI $1.67
- 52 Week High
- PERI $11.79
- MRVI $8.54
- Technical
- Relative Strength Index (RSI)
- PERI 51.75
- MRVI 64.42
- Support Level
- PERI $9.47
- MRVI $3.21
- Resistance Level
- PERI $10.40
- MRVI $3.46
- Average True Range (ATR)
- PERI 0.29
- MRVI 0.20
- MACD
- PERI 0.01
- MRVI 0.02
- Stochastic Oscillator
- PERI 38.40
- MRVI 87.20
About PERI Perion Network Ltd.
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.